[HTML][HTML] Long non-coding RNAs: from disease code to drug role

Y Chen, Z Li, X Chen, S Zhang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Enormous studies have corroborated that long non-coding RNAs (lncRNAs) extensively
participate in crucial physiological processes such as metabolism and immunity, and are …

Recent trends and advances of RNA interference (RNAi) to improve agricultural crops and enhance their resilience to biotic and abiotic stresses

JK Bharathi, R Anandan, LK Benjamin… - Plant Physiology and …, 2023 - Elsevier
Over the last two decades, significant advances have been made using genetic engineering
technology to modify genes from various exotic origins and introduce them into plants to …

Editorial focus: understanding off-target effects as the key to successful RNAi therapy

R Bartoszewski, AF Sikorski - Cellular & molecular biology letters, 2019 - Springer
With the first RNA interference (RNAi) drug (ONPATTRO (patisiran)) on the market, we
witness the RNAi therapy field reaching a critical turning point, when further improvements in …

Cancer therapeutic siRNA delivery and imaging by nitrogen-and neodymium-doped graphene quantum dots

AR Valimukhametova, BH Lee… - ACS biomaterials …, 2023 - ACS Publications
While small interfering RNA (siRNA) technology has become a powerful tool that can enable
cancer-specific gene therapy, its translation to the clinic is still hampered by the inability of …

Engineered Zwitterionic Diblock Copolymer‐siRNA Polyplexes Provide Highly Effective Treatment of Triple‐Negative Breast Cancer in a 4T1 Murine Model

T Jeon, R Goswami, H Nagaraj… - Advanced Functional …, 2024 - Wiley Online Library
Self‐assembly of small interfering RNA (siRNA) with a block copolymer featuring
guanidinium and zwitterion functionalized blocks generates core‐shell‐like nanovectors that …

Clinical pharmacology of RNA interference–based therapeutics: a summary based on Food and Drug Administration–approved small interfering RNAs

X **g, V Arya, KS Reynolds, H Rogers - Drug Metabolism and Disposition, 2023 - Elsevier
RNA-based oligonucleotide therapeutics are revolutionizing drug development for disease
treatment. This class of therapeutics differs from small molecules and protein therapeutics in …

RNA interference approaches for treatment of HIV-1 infection

ML Bobbin, JC Burnett, JJ Rossi - Genome medicine, 2015 - Springer
HIV/AIDS is a chronic and debilitating disease that cannot be cured with current antiretroviral
drugs. While combinatorial antiretroviral therapy (cART) can potently suppress HIV-1 …

The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance

J Seiler, M Breinig, M Caudron-Herger… - Nucleic acids …, 2017 - academic.oup.com
Little is known about the function of most non-coding RNAs (ncRNAs). The majority of long
ncRNAs (lncRNAs) is expressed at very low levels and it is a matter of intense debate …

The neuronal migration hypothesis of dyslexia: A critical evaluation 30 years on

LG Guidi, A Velayos‐Baeza… - European Journal of …, 2018 - Wiley Online Library
The capacity for language is one of the key features underlying the complexity of human
cognition and its evolution. However, little is known about the neurobiological mechanisms …

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era

D Li, FL Mastaglia, S Fletcher… - Medicinal Research …, 2020 - Wiley Online Library
Parkinson's disease (PD) is one of the most common neurodegenerative disorders that
manifest various motor and nonmotor symptoms. Although currently available therapies can …